Crizotinib
CAS 877399-52-5
Overview
Crizotinib is an anti-cancer drug acting as an ALK and ROS1 inhibitor, approved for treatment of some non-small cell lung carcinoma in the US and some other countries, and undergoing clinical trials
Anant Labs manufacture and furnish high quality Crizotinib impurities for global markets. Our Crizotinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
Cat. No.ANT-CZT-00
CAS877399-52-5
Mol. FormulaC21H22Cl2FN5O
Mol. Weight450.34 g/mol
IUPAC3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
SMILESC[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
InChIInChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1
InChI KeyKTEIFNKAUNYNJU-GFCCVEGCSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amineCrizotinib877399-52-5PF-02341066(R)-crizotinibPF-2341066XalkoriPF 2341066(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-aminePF 02341066
